Skip to main content
Premium Trial:

Request an Annual Quote

GeneThera Acquires Majority Stake in Applied Genetics

NEW YORK (GenomeWeb News) – GeneThera today announced it has acquired a majority ownership of molecular diagnostic firm Applied Genetics for an undisclosed amount.

GeneThera said the deal is part of a broader strategy to begin revenue generation at Applied Genetics, which is based in Monterrey, Mexico and focuses on commercializing tests for Johne's disease in Mexico.

GeneThera is a molecular biotech firm based in Westminster, Colo. Its diagnostic solution, it said, is based on a genetic expression assay called GES and Johne's disease management system Herdcheck, which is "designed to function on a highly automated Fluorogenic PCR platform."

GES and Herdcheck are designed for a variety of diseases.

Johne's disease affects dairy cows, sheep, and goats and is caused by Mycobacterium Paratuberculosis sub. Avium (MAP). MAP has been shown in studies to be a cause of Crohn's disease in humans.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.